Health-related quality of life among Chinese people with psoriasis in Hong Kong

Hong Kong Journal of Dermatology and Venereology

Volumn 14, Issue 1, 2006, Pages 5-10

  Tse, C T ^a,b   Ho, K M ^a  

^a Department of Health   (Hong Kong)

^b Kowloon Bay Integrated Treatment Centre   (Hong Kong)

Author keywords

Health related quality of life (HRQOL); Psoriasis; SF 36

Indexed keywords

ADULT; ARTICLE; BRONCHIECTASIS; CHINESE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HONG KONG; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PSORIASIS; QUALITY OF LIFE; SCORING SYSTEM; SEVERE ACUTE RESPIRATORY SYNDROME; SHORT FORM 36;

EID: 33644885427     PISSN: 18147453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Yip SY. The prevalence of psoriasis in the Mongoloid race. J Am Acad Dermatol 1984;10:965-8.
2. Lo KK. Introduction of Skin Diseases. In: Lo KK, Chong LY, Tang YMW, Ho KM, editors. Handbook of Dermatology & Venereology (Vol 1). 3th ed. Social Hygiene Service; 2003:15-25.
3. Koo JYM. Quality of life issues in psoriasis. Available from: URL:http://www.dermnet.com/projet2/NewFiles/koo.htm.
4. Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995; 132:236-44.
5. Lundberg L, Johannesson M, Silverdahl M, Hermansson C, Lindberg M. Health-related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol 2000;80:430-4.
6. Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999;41(3 Pt 1):401-7.
7. Lam CLK, Louder IJ, Lam TP, Gandeck B. Population based norming of the Chinese (HK) version of the SF-36 health survey. HK Pract 1999; 21:460-70.
8. Ware JE, Kosinski M, Keller SF. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston. MA: The Health Institute; 1994.
9. Look CN. Low dose Cyclosporin A (CSA) in the treatment of psoriasis- Hong Kong experience. Social Hygiene Service Bulletin 1995;3:79-83.
10. Chan SL, Chan-Yeung MM, Ooi GC, Lam CL, Cheung TF, Lam WK, Tsang KW. Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis. Chest 2002;122:2030-7.
11. Lam SP, Lau MOL, Chow E, Lee WM, Yeung A, Tang I. Using Chinese Version Short-form Health Survey (SF-36) to Measure the Quality of Life Status of SARS Pulmonary Rehabilitation Program Patients. Abstract in Hong Kong International Conference on Infectious Diseases (HKICID-2004).
12. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001;137:280-4.
13. Weiss SC, Kimball AB, Liewehr DJ, Blauvelt A, Turner ML, Emanuel EJ. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol 2002;47:512-8.
14. Lam CL, Fong DY, Louder IJ, Lam TP. The effect of health-related quality of life (HRQOL) on health service utilisation of a Chinese population. Soc Sci Med 2002; 55:1635-46.
15. Perkins JJ, Sanson-Fisher RW. An examination of self- and telephone-administered modes of administration for the Australian SF-36. J Clin Epidemiol 1998;51:969-73.
16. McHorney CA, Kosinski M, Ware JE Jr. Comparisons of the costs and quality of norms for the SF-36 health survey collected by mail versus telephone interview: results from a national survey. Med Care 1994;32:551-67.